BioVentrix treats first patient in European study of Revivent TC system
BioVentrix has designed REVIVE-HF study to enrol 180 patients to evaluate the treatment of ischemic cardiomyopathy induced heart…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Oct 19
BioVentrix has designed REVIVE-HF study to enrol 180 patients to evaluate the treatment of ischemic cardiomyopathy induced heart…
09 Oct 19
TORUS is an advanced stent graft platform designed for the treatment of peripheral artery disease (PAD) in the…
09 Oct 19
The agreement grants QIAGEN non-exclusive rights to develop and globally commercialize IVD kits to be used together with…
09 Oct 19
The Vantage Ankle Flat Cut Talus is Exactech’s alternative talus option and was designed to address the challenge…
09 Oct 19
Motus GI added medical device sales professionals to support the hospital-focused commercial roll-out of the Pure-Vu System
09 Oct 19
The Radiance 330 proton therapy system at MGH is a compact, single room system equipped with an advanced…
09 Oct 19
The most common side effects observed with eTNS use are: drowsiness, an increase in appetite, trouble sleeping, teeth…
08 Oct 19
The new Digital Anatomy 3D Printer has been designed to recreate the actual tissue response, and is capable…
07 Oct 19
EP Map offers 3D mapping and navigation system with integrated signal recording and pacing system, radiofrequency ablation generator…
07 Oct 19
The HemoStyp device is intended to help stopping the bleeding quicker than normal gauze and is claimed to…